期刊文献+

亲水作用色谱串联质谱法测定人血浆中的拉米夫定 被引量:2

Determination of lamivudine in human plasma by hydrophilic interaction chromatography (HILIC) tandem mass spectrometry
原文传递
导出
摘要 目的:建立简便、快速的亲水作用色谱串联质谱法(HILIC-MS/MS)测定人血浆中的拉米夫定。方法:以13C1,15N2(拉米夫定为内标,血浆样品经乙腈沉淀蛋白后,采用Luna HILIC(100 mm×3.0 mm,3μm)柱分离。流动相为乙腈-5 mmol·L-1醋酸铵-甲酸(95∶5∶0.01,v/v/v),进样体积2μL,样品分析时间3 min。采用ESI源正离子模式、多反应监测(MRM),用于定量分析的离子反应分别为m/z230(112(拉米夫定)和m/z233(115(内标)。结果:测定人血浆中拉米夫定的线性范围为8.0~2000 ng·mL-1,定量下限为8.0 ng·mL-1,日内、日间精密度(RSD)均小于9.0%,准确度(RE)在-7.1%~2.7%之间。本法成功应用于健康受试者口服2种拉米夫定片后的生物等效性研究。结论:采用稳定同位素内标的HILIC-MS/MS法更为简便、快捷和准确,适用于人血浆样品中拉米夫定的测定。 Objective:To develop and validate a hydrophilic interaction chromatography-tandem mass spectrometric(HILIC-MS/MS) method for the determination of lamivudine in human plasma.Method:The plasma sample was protein precipitated with acetonitrile using the stable labelled 13C1,15N2-lamivudine as the internal standard.After sample preparation,the analyte and the IS were separated on a Luna HILIC(100 mm×3.0 mm,3 μm)column using 2 μL injection volume with a run time of 3.0 min.The mobile phase consisited of acetonitrile-5 mmol·L-1 ammonium acetate-formic acid(95∶ 5∶ 0.01,v/v/v).Detection was performed by tandem mass spectrometry using an electrosprasy source(ESI) in the positive ion mode,operating in the multiple reaction monitoring(MRM) of the transitions of m/z 230→112 and m/z 233→115 for lamivudine and the IS,respectively.Results:The linear calibration curves were obtained in the concentration range of 8.0-2000 ng·mL-1.The lower limit of quantification was 8.0 ng·mL-1.The intra-day and inter-day relative standard deviation over the entire concentration range was less than 9.0%.The accuracy was in the range of-7.1% to 2.7% in terms of relative error.The method was applied to evaluate the bioequivalence of two lamivudine tablet formulations in healthy volunteers.Conclusion:This method is simple,selective,rapid and suitable for the determination of lamivudine in human plasma.
出处 《药物分析杂志》 CAS CSCD 北大核心 2011年第8期1448-1452,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 核苷类 抗病毒 拉米夫定 液相色谱 质谱 血浆药物浓度 nucleoside antiviral lamivudine HPLC mass spectrometry(MS) plasma concentration
  • 相关文献

参考文献17

  • 1Jarvis B,Faulds D. Lamivudine:a review of its therapeutic potenti',d in chronic hepatitis B. Drugs, 1999,58 ( 1 ) : 101.
  • 2Alpert AJ. Hydrophilic - interaction chromatography for the separationof peptides, nucleic acids and other polar compounds. J Chromatogr, 1990,499:177.
  • 3Naidong W. Bioanaiytical liquid chromatography tandem mass spectrom- etry methods on underivatized silica colmnns with aqueous/organic mo- bile phases. J Chromatogr B ,2003,796(2) :209.
  • 4Baughman TM, Wright WL, Hutton KA. Determination of zanamivir in rat and monkey plasma by positive ion hydrophilie interaction chroma- tography( HILIC )/tandem mass spectrometry. J Chromatogr B, 2007, 852( 1 -2) :505.
  • 5Hsieh Y. Potential of HILC - MS in quantitative bioml~ysis of drags and drug metabolites. J Sep &'i,200~,31 (9) :1481.
  • 6McCalley DV. Is hydrophilic interaction chromatography with silica col- umns a viable alternative to reversed -phase liquid chromatography for the analysis of ionisable compounds. J Chromatogr A ,2007,171 ( 1 -2) : 46.
  • 7Mistfi HN,Jangid AG,Pudage A,et a/. High throughput LC - MS/MS method for simultaneous quantification of lamivudine,stavudine and ne- virapin in human plasma. J CTzronuztogy B,2007,853( 1 -2) :320.
  • 8Fan B, Bartlett MG, Stewart JT. Determination of lamivudine/stavudine/ efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polm'ity switch. Biomed Chro- matogr,2002,16(6) :383.
  • 9Moore JD,Valette G, Darque A, et al. Simultaneous qumatitation of the 5' -triphosphate metabolites of" zidovudine,lan~/vudine,and stavctdine in peripheral mononuclear blood ceils of HIV infected patients by high - performance liquid chromatography tandem mass spectromett'y. J Am .'~~~c~ Mass Spectrom ,2000 ,11 (12) :1134.
  • 10Yzdav M,Singhal P,Goswanfi S,et al. Selective determination of antiret- roviral aget~ts teno~bvir,emtricitahine,at~d lamivudine in bureau pi~L~ma by a LC - MS - MS meth~~t for a bioequivalence study in he~dthy Indian subjects. J Chromatogr &'i ,2010,48 (9) :704.

同被引文献37

  • 1苏萌,艾连峰.液相色谱-串联质谱基质效应及其消除方法[J].食品安全质量检测学报,2014,5(2):511-515. 被引量:75
  • 2吴琼珠,戴永健,刘卫卫,吴立云.HPLC法检测齐多夫定的有关物质[J].药物分析杂志,2005,25(7):856-858. 被引量:2
  • 3Mitsuya H,Weinhold KJ,Furman PA,et al.3'-azido-3'-deoxythymidine (BW A509U):An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type Ⅲ/lymphadenopathy-associated.Proc Natl Acad Sci USA,1985,82:7096.
  • 4Furman PA,Fyfe JA,Clair MH,et al.Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proc Natl Acad Sci USA,1986,83:8333.
  • 5Nakashima H,Matsui T,Harada S,et al.Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type Ⅲ/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.Antimicrob Agents Chemother,1986,30(6):933.
  • 6Coates JAV,Cammack N,Jenkinson HJ,et al.(-)-2'-deoxy-3'-thiacytidine is a potent,highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.Antimicrob Agents Chemother,1992,36(4):733.
  • 7Sekar R,Azhaguvel S.Simultaneous determination of HIV-protease inhibitors lamivudine and zidovudine in pharmaceutical formulations by micellar electrokinetic chromatography.J Pharm Biomed Anal,2005,39:653.
  • 8Harker AJ,Evans GL,Hawky AE,et al. High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum. J Chromatogr B,1994,657(1):227.
  • 9Zhou XJ,Sommadosi JP.Rapid quantitation of (-)-2'-deoxy-3'-thiacytidine in human serum by high-performance liquid chromatography with ultraviolet detection.J Chromatogr B,1997,691(2):417.
  • 10Unadkat JD,Crosby SS,Wang JP,et al.Simple and rapid high-performance liquid chromatographic assay for zidovudine (azidothymidine) in plasma and urine.J Chromatogr,1988,430:420.

引证文献2

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部